The AI 100 Revealed: The Most Promising Startups of 2025
Meet the startups driving the next wave of AI innovation – and the strategies behind their success.
Meet the startups driving the next wave of AI innovation – and the strategies behind their success.
AI will be the driving force behind tech M&A deals in 2025. From AI agent consolidation to big tech’s next battlefield, we highlight 7 areas where we expect to see deals this year.
From deal activity to top investors, we analyze the shifting landscape for AI in clinical trials to determine how the tech is transforming drug development for the better.
In this webinar, our expert breaks down AI’s impact across the entire R&D pipeline – from discovery to FDA approval.
From clinical operations to drug development, we mapped 85+ startups bringing generative AI to the healthcare and life sciences industries.
We mined the CB Insights database to map 170+ AI agent startups across 26 categories. We also provide an outlook on AI agents’ progress, limitations, and future directions.
From data loss prevention to IoT security, we map 135+ companies helping healthcare organizations combat cyber threats.
Our expert breaks down the biggest trends shaping the dealmaking landscape in 2025.
From the drought in dealmaking to a new record for early-stage companies, we break down the trends reshaping insurtech using CB Insights data.
2024 broke records for AI, with funding surpassing $100B. As the AI arms race intensifies, staying ahead of the trends and opportunities has never been more critical.
CVCs plunge headfirst into AI, prioritize early-stage deals, and downshift on Asia. We break down the trends reshaping corporate venture capital using CB Insights data.
From a new breed of AI unicorns to the M&A wave, we look at key changes in the AI landscape using CB Insights data.
We surveyed 50 senior strategy leaders to understand their genAI implementation tactics — and why some teams are seeing better results than others.
From AI’s ascendance to cautious dealmaking, we break down the trends reshaping digital health in 2024 using CB Insights data.
In this webinar, our expert explores how leading enterprises are integrating genAI into their strategies to drive results and stay ahead of the competition.
From AI’s banner year to an 8-year low in global dealmaking, we break down key changes in the venture landscape using CB Insights data.
AI promises to accelerate the path from bench to bedside. Using CB Insights data, we highlight emerging markets in the preclinical phase that are ripe for pharma investments and partnerships.
How did venture fare in 2024, and what’s ahead for 2025? In this webinar, our expert breaks down the year’s funding landscape, why it matters, and the trends set to shape the future.
We analyze funding and acquisitions data, clinical progress, and partnership strategies to help pharma companies and investors navigate the maturing AI landscape in drug discovery.
Pharma giants and diagnostic testing leaders looking to expand in cancer detection should watch high-momentum liquid biopsy startups like Harbinger Health and Delfi Diagnostics.
Nearly 1 in 2 new unicorns is an AI company. We visualize every billion-dollar startup around the globe and break down emerging areas of opportunity.
The Digital Health 50 is CB Insights’ annual list of the most promising digital health startups in the world.
We mined Roche’s acquisitions, investments, and partnerships to discern the company's strategic priorities. Here’s what pharma and diagnostics companies need to pay attention to.
Discover the key trends our experts anticipate will shape the tech landscape in 2025.
The future of LLMs. Caregiving humanoid robots. Crypto’s baby steps. We use CB Insights data to uncover 15 emerging trends that will shape the tech landscape for years to come.
From in-home humanoids to autonomous labs, we highlight the growing opportunities in robotics markets for providers and other healthcare stakeholders.